Accuray Return on Tangible Equity 2010-2025 | ARAY

Current and historical return on tangible equity values for Accuray (ARAY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Accuray Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.00B $-0.01B -9.09%
2024-12-31 $0.00B $-0.01B 30.19%
2024-09-30 $-0.02B $-0.01B 128.30%
2024-06-30 $-0.02B $-0.01B 136.17%
2024-03-31 $-0.02B $-0.02B 231.58%
2023-12-31 $-0.02B $-0.01B 250.00%
2023-09-30 $-0.01B $-0.01B 140.00%
2023-06-30 $-0.01B $0.00B 150.00%
2023-03-31 $-0.01B $0.00B 144.00%
2022-12-31 $-0.01B $-0.01B 151.72%
2022-09-30 $-0.01B $-0.01B 120.00%
2022-06-30 $-0.01B $-0.01B 62.50%
2022-03-31 $-0.01B $-0.01B 305.88%
2021-12-31 $-0.01B $-0.01B -480.00%
2021-09-30 $-0.01B $-0.01B -77.78%
2021-06-30 $-0.01B $0.01B -41.38%
2021-03-31 $0.01B $0.02B 37.74%
2020-12-31 $0.01B $0.02B 94.12%
2020-09-30 $0.01B $0.01B 430.77%
2020-06-30 $0.01B $0.01B -153.85%
2020-03-31 $0.00B $0.00B -59.26%
2019-12-31 $0.00B $0.00B 0.00%
2019-09-30 $-0.02B $-0.02B 130.61%
2019-06-30 $-0.02B $-0.01B 148.84%
2019-03-31 $-0.02B $-0.01B 145.45%
2018-12-31 $-0.02B $-0.01B 204.26%
2018-09-30 $-0.02B $-0.01B 213.33%
2018-06-30 $-0.02B $-0.01B 218.18%
2018-03-31 $-0.03B $-0.01B 243.48%
2017-12-31 $-0.02B $-0.01B 208.70%
2017-09-30 $-0.03B $-0.01B 219.61%
2017-06-30 $-0.03B $-0.01B 227.45%
2017-03-31 $-0.03B $-0.01B 275.56%
2016-12-31 $-0.03B $-0.02B 277.78%
2016-09-30 $-0.02B $-0.01B 293.33%
2016-06-30 $-0.03B $-0.01B 370.37%
2016-03-31 $-0.02B $-0.01B 505.26%
2015-12-31 $-0.03B $-0.01B 861.54%
2015-09-30 $-0.03B $-0.01B 2133.33%
2015-06-30 $-0.04B $0.00B -8200.00%
2015-03-31 $-0.05B $0.00B -1058.82%
2014-12-31 $-0.05B $0.00B -671.43%
2014-09-30 $-0.04B $0.00B -420.00%
2014-06-30 $-0.04B $0.02B -313.04%
2014-03-31 $-0.05B $0.01B -400.00%
2013-12-31 $-0.07B $0.01B -458.06%
2013-09-30 $-0.10B $0.01B -355.14%
2013-06-30 $-0.10B $0.02B -240.94%
2013-03-31 $-0.10B $0.03B -166.40%
2012-12-31 $-0.09B $0.06B -107.32%
2012-09-30 $-0.07B $0.07B -70.77%
2012-06-30 $-0.07B $0.10B -65.45%
2012-03-31 $-0.08B $0.11B -66.24%
2011-12-31 $-0.06B $0.12B -47.28%
2011-09-30 $-0.05B $0.12B -33.28%
2011-06-30 $-0.03B $0.12B -17.09%
2011-03-31 $0.00B $0.18B 1.77%
2010-12-31 $0.01B $0.17B 3.64%
2010-09-30 $0.00B $0.16B 0.63%
2010-06-30 $0.00B $0.17B 1.92%
2010-03-31 $0.00B $0.16B -0.66%
2009-12-31 $0.00B $0.15B -1.35%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.139B $0.447B
Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $183.740B 80.48
Thermo Fisher Scientific (TMO) United States $157.155B 19.01
Edwards Lifesciences (EW) United States $44.664B 29.28
Alcon (ALC) Switzerland $42.873B 28.97
IDEXX Laboratories (IDXX) United States $41.865B 48.11
DexCom (DXCM) United States $32.988B 50.99
IQVIA Holdings (IQV) United States $27.445B 15.37
Mettler-Toledo (MTD) United States $24.611B 29.27
STERIS (STE) Ireland $22.391B 24.66
SONOVA HOLDING (SONVY) Switzerland $17.259B 0.00
Waters (WAT) United States $17.231B 24.31
Hologic (HOLX) United States $14.231B 15.46
Sysmex ADR (SSMXY) Japan $10.500B 29.79
Penumbra (PEN) United States $9.078B 71.25
Masimo (MASI) United States $8.645B 31.89
Globus Medical (GMED) United States $7.664B 18.26
Glaukos (GKOS) United States $5.628B 0.00
Teleflex (TFX) United States $5.008B 8.27
Integer Holdings (ITGR) United States $4.087B 21.41
TransMedics (TMDX) United States $3.833B 83.32
PROCEPT BioRobotics (PRCT) United States $3.156B 0.00
LivaNova (LIVN) United Kingdom $2.344B 13.96
Nihon Kohden (NHNKY) Japan $2.188B 25.10
Veracyte (VCYT) United States $1.971B 27.66
Elekta AB (EKTAY) Sweden $1.876B 16.86
Alphatec Holdings (ATEC) United States $1.554B 0.00
Artivion (AORT) United States $1.345B 125.96
OPKO Health (OPK) United States $1.079B 0.00
Pulse Biosciences (PLSE) United States $1.058B 0.00
Tandem Diabetes Care (TNDM) United States $1.049B 0.00
Integra LifeSciences Holdings (IART) United States $0.940B 5.00
IRadimed (IRMD) United States $0.736B 37.36
SiBone (SIBN) United States $0.729B 0.00
Semler Scientific (SMLR) United States $0.585B 12.67
Beta Bionics (BBNX) United States $0.549B 0.00
OrthoPediatrics (KIDS) United States $0.548B 0.00
AxoGen (AXGN) United States $0.538B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.530B 8.24
Pacific Biosciences Of California (PACB) United States $0.447B 0.00
Mesa Laboratories (MLAB) United States $0.435B 10.11
ORTHOFIX MEDICAL INC (OFIX) United States $0.419B 0.00
Delcath Systems (DCTH) United States $0.392B 0.00
Treace Medical Concepts (TMCI) United States $0.368B 0.00
AngioDynamics (ANGO) United States $0.349B 0.00
ClearPoint Neuro (CLPT) United States $0.317B 0.00
NeuroPace (NPCE) United States $0.299B 0.00
RxSight (RXST) United States $0.296B 0.00
Alpha Tau Medical (DRTS) Israel $0.260B 0.00
908 Devices (MASS) United States $0.239B 0.00
Neuronetics (STIM) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.228B 13.79
CVRx (CVRX) United States $0.220B 0.00
Monogram Orthopaedics (MGRM) United States $0.211B 0.00
Sight Sciences (SGHT) United States $0.181B 0.00
Inogen (INGN) United States $0.176B 0.00
Spectral Diagnostics (EDTXF) Canada $0.170B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Rapid Micro Biosystems (RPID) United States $0.144B 0.00
Biosig Technologies (BSGM) United States $0.144B 0.00
Lucid Diagnostics (LUCD) United States $0.118B 0.00
Atossa Genetics (ATOS) United States $0.115B 0.00
Anteris Technologies Global (AVR) Australia $0.107B 0.00
Microbot Medical (MBOT) United States $0.093B 0.00
EnVVeno Medical (NVNO) United States $0.075B 0.00
InspireMD (NSPR) United States $0.072B 0.00
Sensus Healthcare (SRTS) United States $0.071B 43.30
Spectral AI (MDAI) United States $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
QT Imaging Holdings (QTIH) United States $0.055B 0.00
EDAP TMS S.A (EDAP) France $0.055B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.22
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.021B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.56
Longview Acquisition II (LGV) United States $0.000B 0.00